Subcutaneous Immunoglobulin Therapy in the Chronic Management of Myasthenia Gravis: A Retrospective Cohort Study.

about

A crucial first randomized controlled trial of thymectomy in non-thymomatous myasthenia gravis Long-term treatment of refractory myasthenia gravis with subcutaneous immunoglobulin.Subcutaneous Immunoglobulins are a Valuable Treatment Option in Myasthenia Gravis.

P2860

Q37411241-B9A56024-5CA8-4CA6-B003-656DA9292B10 Q47145875-5068B71F-054E-462B-B8E5-3CE23A781D0B Q49539814-014E32B4-3328-4370-87BF-69E2BDE7CF9D

P2860

Subcutaneous Immunoglobulin Therapy in the Chronic Management of Myasthenia Gravis: A Retrospective Cohort Study.

Item

http://www.wikidata.org/entity/Q36094658

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Subcutaneous Immunoglobulin Th ...... A Retrospective Cohort Study.

@ast

Subcutaneous Immunoglobulin Th ...... A Retrospective Cohort Study.

@en

type

Item

label

Subcutaneous Immunoglobulin Th ...... A Retrospective Cohort Study.

@ast

Subcutaneous Immunoglobulin Th ...... A Retrospective Cohort Study.

@en

prefLabel

Subcutaneous Immunoglobulin Th ...... A Retrospective Cohort Study.

@ast

Subcutaneous Immunoglobulin Th ...... A Retrospective Cohort Study.

@en

P1476

Subcutaneous Immunoglobulin Th ...... A Retrospective Cohort Study.

@en

P2093

C E Pringle

http://www.w3.org/2001/XMLSchema#string

J Warman Chardon

http://www.w3.org/2001/XMLSchema#string

P R Bourque

http://www.w3.org/2001/XMLSchema#string

W Cameron

http://www.w3.org/2001/XMLSchema#string

P2860

Intravenous immunoglobulin for myasthenia gravis

Future perspectives in target-specific immunotherapies of myasthenia gravis

Less is more, or almost as much: a 15-item quality-of-life instrument for myasthenia gravis.

EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases.

Subcutaneous versus intravenous immunoglobulin in multifocal motor neuropathy: a randomized, single-blinded cross-over trial.

Comparison of IVIg and PLEX in patients with myasthenia gravis.

Subcutaneous immunoglobulin in treating inflammatory neuromuscular disorders.

Subcutaneous immunoglobulin replacement in primary immunodeficiencies.

Higher doses of subcutaneous IgG reduce resource utilization in patients with primary immunodeficiency.

A Retrospective Longitudinal Within-Subject Risk Interval Analysis of Immunoglobulin Treatment for Recurrent Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

P304

e0159993

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0159993

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

J Cowan

P577

2016-08-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27490101

http://www.w3.org/2001/XMLSchema#string

P921

myasthenia gravis

P932

4973986

http://www.w3.org/2001/XMLSchema#string

Subcutaneous Immunoglobulin Therapy in the Chronic Management of Myasthenia Gravis: A Retrospective Cohort Study.

about

P2860

P2860

Subcutaneous Immunoglobulin Therapy in the Chronic Management of Myasthenia Gravis: A Retrospective Cohort Study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932